AAAAAA

   
Results: 1-13 |
Results: 13

Authors: DAMIANI D MICHIELI M ERMACORA A RUSSO D FANIN R ZAJA F BARALDO M PEA F FURLANUT M BACCARANI M
Citation: D. Damiani et al., ADJUVANT TREATMENT WITH CYCLOSPORINE-A INCREASES THE TOXICITY OF CHEMOTHERAPY FOR REMISSION INDUCTION IN ACUTE NONLYMPHOCYTIC LEUKEMIA, Leukemia, 12(8), 1998, pp. 1236-1240

Authors: BENETELLO P FURLANUT M FORTUNATO M PEA F BARALDO M
Citation: P. Benetello et al., LEVODOPA AND 3-O-METHYLDOPA IN CEREBROSPINAL-FLUID AFTER LEVODOPA-CARBIDOPA ASSOCIATION, Pharmacological research, 35(4), 1997, pp. 313-315

Authors: BENETELLO P FURLANUT M FORTUNATO M BARALDO M PEA F TOGNON A TESTA G
Citation: P. Benetello et al., ORAL GABAPENTIN DISPOSITION IN PATIENTS WITH EPILEPSY AFTER A HIGH-PROTEIN MEAL, Epilepsia, 38(10), 1997, pp. 1140-1142

Authors: MICHIELI M DAMIANI D MICHELUTTI A ERMACORA A MASOLINI P PEA F BACCARANI M
Citation: M. Michieli et al., THE LIPOSOMAL FORMULATION OF DAUNOXOME INCREASES DAUNORUBICIN TOXICITY IN MULTI DRUG-RESISTANT CELL-LINES, Blood, 90(10), 1997, pp. 3647-3647

Authors: DAMIANI D PEA F MICHIELI M ERMACORA A BARALDO M RUSSO D FANIN R FURLANUT M BACCARANI M
Citation: D. Damiani et al., MULTIDRUG-RESISTANCE MODULATION IN-VIVO - THE EFFECT OF CYCLOSPORINE ALONE OR WITH DEXTRO-VERAPAMIL ON IDARUBICIN PHARMACOKINETICS IN ACUTE-LEUKEMIA, Blood, 90(10), 1997, pp. 804-804

Authors: MICHIELI M DAMIANI D MICHELUTTI A ERMACORA A MASOLINI P PEA F BACCARANI M FANIN R
Citation: M. Michieli et al., LIPOSOMAL DAUNORUBICIN (DAUNOXOME) PROVIDES INCREASED INTRACELLULAR DRUG ACCUMULATION IN PGP OVEREXPRESSING LEUKEMIC BLAST CELLS, Blood, 90(10), 1997, pp. 1472-1472

Authors: FURLANUT M BARALDO M GALLA F MARZOCCHI V PEA F
Citation: M. Furlanut et al., CYCLOSPORINE NEPHROTOXICITY IN RELATION TO ITS METABOLISM IN PSORIASIS, Pharmacological research, 33(6), 1996, pp. 349-352

Authors: FURLANUT M BARALDO M PEA F MARZOCCHI V CROATTINO L GALLA F
Citation: M. Furlanut et al., BLOOD-CONCENTRATIONS AND CLINICAL EFFECT OF CYCLOSPORINE IN PSORIASIS, Therapeutic drug monitoring, 18(5), 1996, pp. 544-548

Authors: WU G BARALDO M PEA F COSSETTINI P FURLANUT M
Citation: G. Wu et al., EFFECTS OF DIFFERENT SAMPLING STRATEGIES ON PREDICTIONS OF BLOOD CYCLOSPORINE CONCENTRATIONS IN HEMATOLOGICAL PATIENTS WITH MULTIDRUG-RESISTANCE BY BAYESIAN AND NONLINEAR LEAST-SQUARES METHODS, Pharmacological research, 32(6), 1995, pp. 355-362

Authors: DAMIANI D MICHIELI M MICHELUTTI A PEA F BARALDO M FANIN R RUSSO D FURLANUT M BACCARANI M
Citation: D. Damiani et al., P170-RELATED MULTIDRUG-RESISTANCE - ENHANCEMENT OF IDARUBICIN CONTENTIN LEUKEMIC-CELLS WITH CYCLOSPORINE IN-VIVO - A REPORT OF 2 CASES, Leukemia, 9(10), 1995, pp. 1792-1795

Authors: PEA F MIGLIOLI PA MAZZO M BERTI T
Citation: F. Pea et al., STUDY ON THE BACTERICIDAL ACTIVITY AND SYNERGISTIC EFFECT OF NEUTROPENIC RAT SERUM WITH GENTAMICIN, Journal of chemotherapy, 6(2), 1994, pp. 117-120

Authors: FURLANUT M BARALDO M PEA F ALBANESE MC ALBERTINI A PURICELLI C
Citation: M. Furlanut et al., EFFECT OF FLUCTUATIONS OF BLOOD CYCLOSPORINE CONCENTRATIONS ON RENAL-FUNCTION, Transplantation proceedings, 26(5), 1994, pp. 2574-2575

Authors: BENEDETTI L CORTIVO R BERTI T BERTI A PEA F MAZZO M MORAS M ABATANGELO G
Citation: L. Benedetti et al., BIOCOMPATIBILITY AND BIODEGRADATION OF DIFFERENT HYALURONAN DERIVATIVES (HYAFF) IMPLANTED IN RATS, Biomaterials, 14(15), 1993, pp. 1154-1160
Risultati: 1-13 |